The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Warrior Sports, Inc. v. Reebok Int'l Ltd.

The firm served as lead counsel on behalf of Reebok in a patent infringement case relating to multiple patents on more

Mr. Electric Corp. v. Reiad Khalil, et. al.
Achieved a win on behalf of our client, The Dwyer Group, and specifically its Mr. Electric subsidiary, against Alber Electric, a business operated by more
Unfair competition actions on behalf of major bottled water company
Represented a major bottled water company in unfair competition actions relative to advertising claims. more
Sale of pathology laboratory
Represented seller in the sale of pathology laboratory through the sale of shares following spinoff of anatomic laboratory to shareholder. more